期刊文献+

Clinical Observation of Transepithelial Corneal Collagen Cross-linking by Iontophoresis of Riboflavin in Treatment of Keratoconus 被引量:15

Clinical Observation of Transepithelial Corneal Collagen Cross-linking by Iontophoresis of Riboflavin in Treatment of Keratoconus
下载PDF
导出
摘要 Purpose: To evaluate the efficacy and safety of transepithelial collagen cross-linking by iontophoretic delivery of riboflavin in treatment of progressive keratoconus.Methods:.Eleven patients(15 eyes) with progressive keratoconus were enrolled. After 0.1% riboflavin-distilled water solution was deliveried via transepithelial iontophpresis for 5 min with 1 m A current, and ultraviolet radiation(370 nm,.3 m W /cm2) was performed at a 1.5 cm distance for 30 min. The follow up were 6 months in all eyes. The uncorrected visual acuity, corrected visual acuity,endothelial cell counting, corneal thickness,.intraocular pressure, corneal curvature, corneal topography,.OCT and corneal opacity before and 6-month after surgery were analyzed.Results: At 6 month postoperatively, mean uncorrected visual acuity and corrected visual acuity changed from 0.36 to 0.30 and from 0.42 to 0.57 without statistical significance..The mean value of each index of corneal curvature declined without statistical significance.Kmax value dereased from 60.91 to59.91, and the astigmatism declined from 3.86 to 3.19. Central corneal thickness decreased from 460.93 μm to 455.40μm,.and thinnest corneal thickness declined from 450.87 μm to 440.60 μm with no statistical significance..Intraocular pressure was significantly elevated from 10.85 mm Hg to 12.62 mm Hg. Endothelial cell count did not change significantly. No corneal haze occurred. Mean depth of corneal demarcation line was 288.46 μm at 1 month postoperatively..Conclusion:.Transepithelial corneal collagen cross-linking by iontophoresis is effective and safe in the treatment of progressive keratoconus, and yields stable clinical outcomes during 6-month follow up..However,.long-term follow up is urgently required. Purpose: To evaluate the efficacy and safety of transepithelial collagen cross-linking by iontophoretic delivery of riboflavin in treatment of progressive keratoconus. Methods: Eleven patients (15 eyes) with progressive kerato- conus were enrolled. After 0.1% riboflavin-distilled water so- lution was deliveried via transepithelial iontophpresis for 5 min with 1 mA current, and ultraviolet radiation (370 nm, 3 mW/ cm2) was performed at a 1.5 cm distance for 30 min. The fol- low up were 6 months in all eyes. The uncorrected visual acu- ity, corrected visual acuity,endothelial cell counting, corneal thickness, intraocular pressure, corneal curvature, corneal to- pography, OCT and corneal opacity before and 6-month after surgery were analyzed. Results: At 6 month postoperatively, mean uncorrected visual acuity and corrected visual acuity changed from 0.36 to 0.30 and from 0.42 to 0.57 without statistical significance. The mean value of each index of corneal curvature declined with- out statistical significance.Kmax value dereased from 60.91 to 59.91, and the astigmatism declined from 3.86 to 3.19. Cen- tral corneal thickness decreased from 460.93 μm to 455.40 μm, and thinnest corneal thickness declined from 450.87 μm to 440.60 μm with no statistical significance. Intraocular pres- sure was significantly elevated from 10.85 mmHg to 12.62 mmHg. Endothelial cell count did not change significantly. No corneal haze occurred. Mean depth of corneal demarcation line was 288.46 μm at 1 month postoperatively.
出处 《Eye Science》 CAS 2014年第3期160-164,共5页 眼科学报(英文版)
关键词 角膜混浊 核黄素 皮胶原 临床观察 圆锥 离子 导入 联通 keratoconus corneal collagen cross-linking ion-tophoresis treatment outcome
  • 相关文献

参考文献2

二级参考文献28

  • 1Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res 1998; 66:97-103.
  • 2Wollensak G. Cross linking treatment of progressive ker- atoconus: new hope. Curr Opin Ophthalmol 2006; 17 : 356-360.
  • 3McCall AS, Kraft S, Edelhauser HF, et al. Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci 2010;51: 129-138.
  • 4Kamaev P, Friedman MD, Sherr E, et al. Photochemical kinetics of corneal cross-linking with riboflavin. Invest Ophthalmol Vis Sci 2012; 53 : 2360-2367.
  • 5Raiskup F, Spoerl E. Corneal crosslinking with r~boflavin and ultraviolet A. Part II. Clinical indications and results. Ocul Surf 2013; 11 :93-108. stroma.
  • 6Hayes S, O'Brart DP, Lamdin LS, et al. Effect of com- plete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg 2008; 34: 657-661.
  • 7Samaras K, O'brart DP, Doutch J, et al. Effect of ep- ithelial retention and removal on riboflavin absorption in porcine corneas. J Refract Surg 2009;25:771-775.
  • 8Baiocchi S, Mazzotta C, Cerretani D, et al. Corneal crosslinking: riboflavin concentration in cornealexposed with and without epithelium. J Cataract Refract Surg 2009; 35: 893-899.
  • 9Botto KM, Schor P, Dreyfuss JL, et al. Effect of corneal epithelium on ultraviolet-A and riboflavin ab- sorption. Arq Bras Oftalmol 2011;74:348-351.
  • 10Zhang ZY, Zhang XR. Efficacy and safety of transepithe- lial corneal collagen crosslinking. J Cataract Refract Surg 2012 ; 38:1304-1305.

共引文献15

同被引文献7

引证文献15

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部